Skip to main content
. 2024 Oct 11;25:361. doi: 10.1186/s12875-024-02609-9

Table 1.

Characteristics of the entire sample and by adherence/non-adherent groups

Variable All (N = 345) Non-adherent (N = 194; 56%) Adherent
(N = 151; 44%)
Univariate logistic regression: Predicting adherence
N or M % or SD N or M % or SD N or M % or SD OR 95% LL 95% UL p
Age 37.6 13.2 36.1 13.3 39.4 12.8 1.02 1.00 1.04 0.021
Sex
 Female 132 38.3 53 40.2 79 59.9 REF
 Male 213 61.7 141 66.2 72 33.8 0.34 0.22 0.54 < 0.001
Race
 Black or African American 44 12.8 33 75.0 11 25.0 0.36 0.18 0.75 0.07
 Other or Unknown Race 32 9.3 21 65.6 11 34.4 0.57 0.26 1.23 0.89
 White 269 78.0 140 52.0 129 48.0 REF
Ethnicity
 Hispanic or Latino 12 3.5 9 75.0 3 25.0 0.41 0.11 1.55 0.23
 Not Hispanic or Latino 302 87.5 173 56.2 135 43.8 REF
 Unknown 31 9.0 18 58.1 13 41.9 0.89 0.42 1.89 0.51
Social Vulnerability Index
 Socioeconomic %tile 0.34 0.27 0.33 0.26 0.34 0.27 1.10 0.49 2.45 0.83
 Household Composition %ile 0.44 0.27 0.43 0.27 0.44 0.26 1.11 0.50 2.49 0.79
 Minority Status/Language %ile 0.44 0.26 0.44 0.26 0.45 0.26 1.19 0.52 2.70 0.69
 Housing Type/Transportation %ile 0.55 0.29 0.57 0.29 0.53 0.29 0.63 0.31 1.31 0.22
 Overall 0.41 0.28 0.42 0.28 0.41 0.30 0.96 0.45 2.02 0.90
Insurance (at index encounter)
 Commercial 119 35.3 55 46.2 64 53.8 1.82 1.16 2.86 0.009
 Medicare 44 13.1 24 54.6 20 45.5 1.06 0.56 2.00 0.86
 Medicaid 196 58.2 123 62.8 73 37.2 0.51 0.33 0.79 0.003
 State subsidized 5 1.5 2 40.0 3 60.0 1.91 0.32 11.59 0.48
 Other Insurance 66 19.6 36 54.6 30 45.5 1.00 0.58 1.70 0.99
 None 8 2.4 6 75.0 2 25.0 0.41 0.08 2.08 0.28
Smoking status (at index) < 0.001
 Smoker 194 57.6 122 62.9 72 37.1 REF
 Nonsmoker 54 16.0 32 59.3 22 40.7 1.17 0.63 2.16 0.25
 Former Smoker 89 26.4 34 38.2 55 61.8 2.74 1.63 4.60 < 0.001
Comorbid Substance Use Disorders
 Alcohol use disorder 46 13.3 28 60.9 18 39.1 0.80 0.43 1.50 0.50
 Cocaine use disorder 19 5.5 16 84.2 3 15.8 0.23 0.06 0.79 0.02
 Stimulant use disorder 51 14.8 34 66.7 17 33.3 0.60 0.32 1.12 0.11
Comorbid Mental Health Disorders
 Anxiety 232 67.3 123 53.0 109 47.0 1.50 0.95 2.37 0.09
 Depression 171 49.6 93 54.4 78 45.6 1.16 0.76 1.78 0.49
 Personality disorder 16 4.6 7 43.8 9 56.3 1.69 0.62 4.66 0.31
 PTSD 51 14.5 26 51.0 25 49.0 1.28 0.71 2.33 0.41
 Serious Mental Illness 45 13 25 55.6 20 44.4 1.03 0.55 1.94 0.92
Comorbid Physical Health Conditions
 Chronic Pain 146 42.3 73 49.7 74 50.3 1.63 1.06 2.51 0.027
 Diabetes 23 6.7 15 65.2 8 34.8 0.67 0.28 1.62 0.37
 Hepatitis C 17 4.9 12 70.6 5 29.4 0.52 0.18 1.51 0.23
 Hypertension 84 24.4 37 44.1 47 56.0 1.92 1.17 3.15 0.01
Buprenorphine
 Average Days Supply 21.4 8.3 18.7 8.1 24.9 6.0 1.12 1.08 1.15 < 0.001
 Daily dose (mg) 11.3 6.2 10.8 6.0 12.0 6.4 1.03 1.00 1.07 0.08
 Formulation
  All Films 229 66.4 128 55.9 101 44.1 1.04 0.66 1.63 0.86
  All Tabs 48 13.9 22 45.8 26 54.2 1.63 0.88 3.00 0.12
  Mix formulations 68 19.7 44 64.7 24 35.3 0.64 0.37 1.12 0.12
Encounter Types
 Any behavioral health 63 18.3 28 44.4 35 55.6 1.79 1.03 3.10 0.039
 Any addiction medicine 10 2.9 8 80.0 2 20.0 0.31 0.07 1.49 0.14
 Any pain medicine 65 18.8 35 53.9 30 46.2 1.13 0.66 1.94 0.67
Urine Toxicology Screens
 Unexpected Positive (Amphetamines) 25 7.3 19 76.0 6 24.0 0.38 0.15 0.98 0.045
 Unexpected Positive (Benzodiazepines) 18 5.2 11 61.1 7 38.9 0.81 0.31 2.14 0.67
 Unexpected Positive (Cocaine) 24 7.0 17 70.8 7 29.2 0.51 0.20 1.25 0.14
 Unexpected Positive (Opioids) 58 16.8 43 74.1 15 25.9 0.39 0.21 0.73 0.003
Unexpected Negative (Buprenorphine) 74 21.5 46 62.2 28 37.8 0.73 0.43 1.24 0.25

Note. M = Mean. SD = Standard deviation. OR = Odds Ratio. LL = 95th percentile lower limit. UL = 95th percentile upper limit. REF = Reference group. p = p-value.